Список литературы

1. Lier H, Schlembach D, Korte W, von Heymann C, Steppat S, M, Maul H, Henrich W, Rath W, Wacker J, Kainer F, Surbek D, Helmer H. [The new German guideline on postpartum haemorrhage (PPH): essential aspects for coagulation and circulatory therapy]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2016; 51(9): 526 - 35. doi: 10 1055/s-0042-105937.

2. Mavrides E, Allard S, Chandraharan E, Collins P, Green L, Hunt B, Riris S, Thomson A. on behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and Management of Postpartum Haemorrhage. BJOG An Int J Obstet Gynaecol. 2017; 124(5): e106 - 49. doi: 10.1111/1471-0528.14178.

3. Takeda S, Makino S, Takeda J, Kanayama N, Kubo T, Nakai A, Suzuki S, Seki H, Terui K, Inaba S, Miyata S. Japanese Clinical Practice Guide for Critical Obstetrical Hemorrhage (2017 revision). J Obstet Gynaecol Res. 2017; 43(10); 1517 - 21. doi: 10.1111/jog. 13417.

4. Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017; 130(4): e168 - 86. doi: 10.1097/AOG.0000000000002351.

5. LeBas A., Chandraharan E., Addei A. AS. Use of the "obstetric shock index" as an adjunctinid entify in signify cant blood loss in patients with massive postpartum hemorrhage. IntJ GynaecolObstet. 2014; 124(3): 253 - 5.

6. Shields LE, Wiesner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improve patient safety. Am J Obstet Gynecol. 2015; 212(3): 272 - 80. doi: 10.1016/j.ajog.2014.07.012.

7. Russell RT. WHO guidelines for the management of postpartum haemorrhage and retained placenta. Hum Fertil. 2011; 14(2): 129 - 129. doi: 10.3109/14647273.2010.529650.

8. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008; 22(6): 999 - 1012. doi: 10.1016/j.bpobgyn.2008.08.004.

9. Say L, Chou D, Gemmill A, , Moller A-B, Daniels J, AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Heal. 2014; 2(6): e323 - 33. doi:10.1016/S2214-109X(14)70227-X.

10. Creanga AA, Berg CJ, Ko JY, Farr SL, Tong VT, Bruce FC, Callaghan WM. Maternal mortality and morbidity in the United States: where are we now? J Womens Health (Larchmt). 2014; 23(1): 3 - 9. doi: 10.1089/jwh.2013.4617.

11. Mallett S. AM. Point-of-care monitoring of haemostasis. Anaesthesia. 2015; 70(1): 73 - 7.

12. Fowler A. PD. Laboratory monitoring of haemostasis. Anaesthesia. 2015; 70(1): 68 - 72.

13. Brooks M, Legendre G, Brun S, Bouet P-E, Mendes LP, Merlot B, Sentilhes L. Use of a Visual Aid in addition to a Collector Bag to Evaluate Postpartum Blood loss: A Prospective Simulation Study. Sci Rep. 2017; 7: 46333. doi:10.1038/srep46333.

14. Lilley G, Burkett-St-Laurent D, Precious E, Bruynseels D, Kaye A, Sanders J, Alikhan R, Collins PW, Hall JE, Collis RE. Measurement of blood loss during postpartum haemorrhage. Int J Obstet Anesth. 2015; 24(1): 8 - 14. doi: 10.1016/j.ijoa.2014.07.009.

15. Diaz V, Abalos E CG. Methods for blood loss estimation after vaginal birth. Cochrane Database SystRev. 2018; Sep13(9).

16. Patel A, Goudar SS, Geller SE, Kodkany BS, Edlavitch SA, Wagh K, Patted SS, Naik VA, Moss N, Derman RJ. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int J Gynaecol Obstet. 2006; 93(3): 220 - 4. doi: 10.1016/j.ijgo.2006.02.014.

17. Glover P. Blood loss at delivery: how accurate is your estimation? Aust J Midwifery 2003; 16(2): 21 - 4.

18. Al Kadri HMF, Al Anazi BK, Tamim HM. Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study. Arch Gynecol Obstet. 2011; 283(6): 1207 - 13. doi: 10.1007/s00404-010-1522-1.

19. Zuckerwise LC, Pettker CM, Illuzzi J, Raab CR, Lipkind HS. Use of a novel visual aid to improve estimation of obstetric blood loss. Obstet Gynecol. 2014; 123(5): 982 - 6

doi: 10.1097/AOG.0000000000000233.

20. Girault A, Deneux-Tharaux C, Sentilhes L, Maillard F, Goffinet F. Undiagnosed abnormal postpartum blood loss: Incidence and risk factors. PLoS One. 2018; 13(1): e0190845.

doi: 10.1371/joumal.pone.0190845.

21. American College of Surgeons Committee on Trauma. Student Manual 9th Edition. Chicago, IL: American College of Surgeons. 2012.

22. Knight M, Nair M, Tuffnell D, Kenyon S, Shakespeare J, Brocklehurst P KJ. Surveillance of maternal deaths in the UK 2012 - 14 and lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2009 - 14. 2016.

23. Green M, Rider C, Ratcliff D, Woodring BC, Developing a Systematic Approach to Obstetric Emergencies. J Obstet Gynecol neonatal Nurs JOGNN 44(5) 677 - 82 doi: 10.1111/1552-6909.12729.

24. Bajaj K, Rivera-Chiauzzi EY, Lee C, Shepard C, Bernstein PS, Moore-Murray T, Smith H, Nathan L, Walker K, Chazotte C, Goffman D. Validating Obstetric Emergency Checklists using Simulation: A Randomized Controlled Trial. Am J Perinatol. 2016; 33(12) 1182 - 90 doi: 10.1055/s-0036-1586118.

25. Guise J-M, Mladenovic J. In situ simulation: identification of systems issues. Semin Perinatol. 2013; 37(3): 161 - 5. doi: 10.1053/j.semperi.2013.02.007.

26. Guise J-M, Lowe NK, Deering S, Lewis PO, O'Haire C, Irwin LK, Blaser M, Wood LS, Kanki BG. Mobile in situ obstetric emergency simulation and teamwork training to improve maternal-fetal safety in hospitals. Jt Comm J Qual patient Saf. 2010; 36(10): 443 - 53.

27. Obstetric Care Consensus No. 5: Severe Maternal Morbidity: Screening and Review. Obstet Gynecol. 2016; 128(3): e54 - 60. doi: 10.1097/AOG.0000000000001642.

28. American College of Obstetricians and Gynecologists Committee on Patient Safety and Quality Improvement. Committee opinion no. 590: preparing for clinical emergencies in obstetrics and gynecology. Obstet Gynecol. 2014; 123(3): 722 - 5.

doi: 10.1097/01.AOG.0000444442.04111.c6.

29. Likis F, Sathe N, Morgans A, Hartmann K, Young J, Carlson-Bremer D, Schorn M, Surawicz T, Andrews J. Management of Postpartum Hemorrhage. Comparative Effectiveness Review No. 151. (Prepared by the Vanderbilt Evidence-based Practice Center under Contract No. 290-2012-00009-1.) AHRQ Publication No. 15-EHC013-EF. Rockville, MD: Agency for Healthcare Researc.

30. Рекомендации ВОЗ по профилактике и лечению послеродового кровотечения, 2012. - 43 с. http://apps.who.int/iris/bitstream/handle/10665/75411/9789244548509_rus.pdf.

31. Gutierrez MC, Goodnough LT, Druzin M, Butwick AJ. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth. 2012; 21(3): 230 - 5. doi: 10.1016/j.ijoa.2012.03.005.

32. Ahonen J, Jokela R, Korttila K. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage. Acta Anaesthesiol Scand. 2007 51(7) 929 - 36. doi: 10.1111/j.1399-6576.2007.01323.x.

33. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2017; 389(10084): 2105 - 16. doi: 10.1016/S0140-6736(17)30638-4.

34. Schlembach D, Helmer H, Henrich W, von Heymann C, Kainer F, Korte W, M, Lier H, Maul H, Rath W, Steppat S, Surbek D, Wacker J. Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016). Geburtshilfe Frauenheilkd. 2018; 78(4): 382 - 99. doi: 10.1055/a-0582-0122.

35. Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion. 2007; 47(9): 1564 - 72. doi: 10.1111/j.1537-2995.2007.01404.x.

36. Grottke O, Levy JH. Prothrombin complex concentrates in trauma and perioperative bleeding. Anesthesiology. 2015; 122(4): 923 - 31. doi:10.1097/ALN.0000000000000608.

37. Dzik WH, Blajchman MA, Fergusson D, Hameed M, Henry B, Kirkpatrick AW, Korogyi T, Logsetty S, Skeate RC, Stanworth S, MacAdams C, Muirhead B. Clinical review: Canadian National Advisory Committee on Blood and Blood Products-Massive transfusion consensus conference 2011: report of the panel. Crit Care. 2011; 15(6): 242. doi: 10.1186/ccl0498.

38. Mavrides E, Allard S, Chaandraharan E et al. On behalf of the Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. BJORG. 2016; 124.

39. Berg CJ, Harper MA, Atkinson SM, Bell EA, Brown HL, Hage ML, Mitra AG, Moise KJ, Callaghan WM. Preventability of pregnancy-related deaths: results of a state-wide review. Obstet Gynecol. 2005; 106(6): 1228 - 34. doi: 10.1097/01.AOG.0000187894.71913.e8.

40. Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008; 199(1): 36.el-5; discussion 91-2. e7 - 11. doi: 10.1016/j.ajog.2008.03.007.

41. Callaghan WM, Kuklina E V, Berg CJ. Trends in postpartum hemorrhage: United States, 1994 - 2006. Am J Obstet Gynecol. 2010; 202(4): 353.e1-6. doi: 10.1016/j.ajog.2010.01.011.

42. Callaghan WM, Mackay AP, Berg CJ. Identification of severe maternal morbidity during delivery hospitalizations, United States, 1991 - 2003. Am J Obstet Gynecol. 2008; 199(2): 133.e1-8. doi: 10.1016/j.ajog.2007.12.020.

43. Kavle JA, Stoltzfus RJ, Witter F, Tielsch JM, Khalfan SS, Caulfield LE. Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr. 2008; 26(2): 232 - 40.

44. Soltani H, Hutchon DR, Poulose TA. Timing of prophylactic uterotonics for the third stage of labour after vaginal birth. Cochrane database Syst Rev. 2010; (8): CD006173.

doi: 10.1002/14651858.CD006173.pub2.

45. Oladapo OT, Okusanya BO, Abalos E. Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane database Syst Rev. 2018; 9: CD009332.

doi: 10.1002/14651858. CD009332. pub3.

46. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane database Syst Rev. 2014;(2):CD003249.

doi: 10.1002/14651858.CD003249.pub3.

47. Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage. Cochrane database Syst Rev. 2013; (10): CD001808. doi: 10.1002/14651858.CD001808.pub2.

48. Novikova N, Hofmeyr GJ, Cluver C. Tranexamic acid for preventing postpartum haemorrhage. Cochrane database SystRev. 2015; (6): CD007872.

doi: 10.1002/14651858. CD007872.pub3.

49. Franchini M, Mengoli C, Cruciani M, Bergamini V, Presti F, Marano G, Pupella S, Vaglio S, Masiello F, Veropalumbo E, Piccinini V, Pati I, Liumbruno GM. Safety and efficacy of tranexamic acid for prevention of obstetric haemorrhage: an updated systematic review and meta-analysis. Blood Transfus. 2018; 16(4): 329 - 37.

doi: 10.2450/2018.0026-18.

50. Shakur H, Beaumont D, Pavord S, Gayet-Ageron A, Ker K, Mousa HA. Antifibrinolytic drugs for treating primary postpartum haemorrhage. Cochrane database Syst Rev. 2018; 2: CD012964. doi: 10.1002/14651858.CD012964.

51. WHO Guidelines Approved by the Guidelines Review Committee. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage. Geneva: World Health Organization; 2018.

52. Jin B, Du Y, Zhang F, Zhang K, Wang L, Cui L, Carbetocin for the prevention of postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. J Matem Fetal Neonatal Med. 2016; 29(3): 400 - 7.

doi: 10.3109/14767058.2014.1002394.

53. Su L-L, Chong Y-S, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane database Syst Rev. 2012; (4): CD005457.

doi: 10.1002/14651858.CD005457.pub4.

54. Su L-L, Chong Y-S, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane database Syst Rev. 2012; (4): CD005457.

doi: 10.1002/14651858.CD005457.pub4.

55. Anandakrishnan S, Balki M, Farine D, Seaward G, Carvalho JCA. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2. Can J Anaesth. 2013; 60(11): 1054 - 60. doi: 10.1007/s12630-013-0028-2.

56. Dyer RA, van Dyk D, Dresner A. The use of uterotonic drugs during caesarean section. Int J Obstet Anesth. 2010; 19(3): 313 - 9. doi: 10.1016/j.ijoa.2010.04.0U.

57. WHO recommendations: uterotonics for the prevention of postpartum haemorrhage.

World Heal Organ. 2018; 53 p.

58. Leung SW, Ng PS, Wong WY, Cheung TH. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG. 2006; 113(12): 1459 - 64. doi: 10.1111/j. 1471-0528.2006.01105.x.

59. Шифман Е.М., Куликов А.В. ПДН и др. Анестезия и интенсивная терапия при массивной кровопотере в акушерстве. Клинические рекомендации (протоколы лечения). Вопросы акушерства, гинекологии, перинатологии. 2018; 17(3): 81 - 100.

60. Cannon JW. Hemorrhagic Shock. N Engl J Med. 2018; 378(4): 370 - 9. doi: 10.1056/NEJMra 1705649.

61. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014; 40(12): 1795 - 815. doi: 10.1007/s00134-014-3525-z.

62. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001; 86(5): 1327 - 30.

63. Squizzato A, Hunt BJ, Kinasewitz GT, Wada H, Ten Cate H, Thachil J, Levi M, Vicente V, D'Angelo A, Di Nisio M. Supportive management strategies for disseminated intravascular coagulation. An international consensus. Thromb Haemost. 2016; 115(5): 896 - 904.

doi: 10.1160/TH15-09-0740.

64. Erez O. Disseminated intravascular coagulation in pregnancy - Clinical phenotypes and diagnostic scores. Thromb Res. 2017; 151 Suppl: S56-S60. doi:10.1016/S0049-3848(17)30069-5.

65. Clark SL, Romero R, Dildy GA, Callaghan WM, Smiley RM, Bracey A W, Hankins GD, D'Alton ME, Foley M, Pacheco LD, Vadhera RB, Herlihy JP, Berkowitz RL, Belfort MA. Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies. Am J Obstet Gynecol. 2016; 215(4): 408 - 12. doi: 10.1016/j.ajog.2016.06.037.

66. Lyndon A, Lagrew D, Shields L, Main E, Cape V. Improving health care response to obstetric hemorrhage version 2.0. A California quality improvement toolkit. Stamford (CA): California Maternal Quality Care Collaborative; Sacramento (CA): California Department of Public Health. 2015;

67. A, Wetterslev J, Moller AM, Afshari A. Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia. 2017; 72(4): 519 - 31. doi: 10.1111/anae. 13765.

68. A, Wetterslev J, Meller AM, Afshari A. Thromboelastography (TEG) or thromboelastometry (ROTEM) to monitor haemostatic treatment versus usual care in adults or children with bleeding. Cochrane database Syst Rev. 2016; (8): CD007871. doi: 10.1002/14651858.CD007871.pub3.

69. Fahrendorff M, Oliveri RS, Johansson PI. The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products - A systematic review and metaanalysis. Scand J Trauma Resusc Emerg Med. 2017; 25(1): 39. doi: 10.1186/sl3049-017-0378-9.

70. Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J. Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. Health Technol Assess. 2015; 19(58): 1 - 228, v-vi. doi: 10.3310/htal9580.

71. Llau J V, Acosta FJ, Escolar G, E, Guasch E, Marco P, Paniagua P, JA, Quintana M, Torrabadella P. Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document). Med intensiva. 2015; 39(8): 483 - 504. doi: 10.1016/j .medin.2015.05.002.

72. Queensland clinical guidelines. Primary postpartum haemorrage.

73. Kozek-Langenecker SA. Fluids and coagulation. Curr Opin Crit Care. 2015; 21(4): 285 - 91. doi: 10.1097/MCC.0000000000000219.

74. Sommer N, B, Candinas D, Haltmeier T. Massive transfusion protocols in nontrauma patients: A systematic review and meta-analysis. J Trauma Acute Care Surg. 2019; 86(3): 493 - 504. doi: 10.1097/TA.0000000000002101.

75. Tanaka H, Matsunaga S, Yamashita T, Okutomi T, Sakurai A, Sekizawa A, Hasegawa J, Terui K, Miyake Y, Murotsuki J, Ikeda T. A systematic review of massive transfusion protocol in obstetrics. Taiwan J Obstet Gynecol. 2017; 56(6): 715 - 8. doi: 10.1016/j.tjog.2017.10.001.

76. Bhangu A, Nepogodiev D, Doughty H, Bowley DM. Meta-analysis of plasma to red blood cell ratios and mortality in massive blood transfusions for trauma. Injury. 2013; 44(12): 1693 - 9. doi: 10.1016/j.injury.2012.07.193.

77. Snegovskikh D, Souza D, Walton Z, Dai F, Rachler R, Garay A, Snegovskikh V V, Braveman FR, Norwitz ER. Point-of-care viscoelastic testing improves the outcome of pregnancies complicated by severe postpartum hemorrhage. J Clin Anesth. 2018; 44: 50 - 6. doi: 10.1016/j.jclinane.2017.10.003.

78. Butwick AJ, Goodnough LT. Transfusion and coagulation management in major obstetric hemorrhage. Curr Opin Anaesthesiol. 2015; 28(3): 275 - 84. doi: 10.1097/ACO.0000000000000180.

79. Collis RE, Collins PW. Haemostatic management of obstetric haemorrhage. Anaesthesia. 2015; 70 Suppl 1: 78 - 86, e27 - 8. doi: 10.1111/anae.12913.

80. Postpartum Haemorrhage, Prevention and Management (Green-top Guideline No. 52). December 2016.

81. Reddy S, Weinberg L, Young P. Crystalloid fluid therapy. Crit Care. 2016; 20(20): 59. doi: 10.1186/s13054-016-1217-5.

82. National Clinical Guideline Centre (UK). Intravenous Fluid Therapy: Intravenous Fluid Therapy in Adults in Hospital. R Coll Physicians. 2013;

83. Kozek-Langenecker SA, Afshari A, Albaladejo P, Santullano CAA, De Robertis E, Filipescu DC, Fries D, K, Haas T, Imberger G, Jacob M, M, Llau J, Mallett S, Meier J, Rahe-Meyer N, Samama CM, Smith A, Solomon C, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013; 30(6): 270 - 382. doi: 10.1097/EJA.0b013e32835f4d5b.

84. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, E, Filipescu D, Hunt BJ, Komadina R, Nardi G, Neugebauer EAM, Ozier Y, Riddez L, Schultz A, Vincent J-L, Spahn DR. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20(1): 100. doi: 10.1186/s13054-016-1265-x.

85. 67. American Society of Anesthesiologists Task Force on Perioperative Blood Management. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology. 2015; 122(2): 241 - 75.

86. Blood Transfusion in Obstetrics Royal College of Obstetricians and Gynaecologists/. RCOG Green-top Guidel No 47. 2015; 23 p.

87. Hovaguimian F, Myles PS. Restrictive versus Liberal Transfusion Strategy in the Perioperative and Acute Care Settings: A Context-specific Systematic Review and Metaanalysis of Randomized Controlled Trials. Anesthesiology. 2016; 125(1): 46 - 61.

doi: 10.1097/ALN.0000000000001162.

88. Goucher H, Wong CA, Patel SK, Toledo P. Cell Salvage in Obstetrics. Anesth Analg. 2015; 121 (2): 465 - 8. doi: 10.1213/ANE.0000000000000786.

89. Доброхотова Ю.Э., Джобава Э.М., Данелян С.Ж., Залесская С.А. Послеродовые кровотечения. Обоснование оптимальной гемостатической фармакотерапии. Российский вестник акушера-гинеколога. 2013; (6): 99 - 102.

90. Bolliger D, Mauermann E, Tanaka KA. Thresholds for Perioperative Administration of Hemostatic Blood Components and Coagulation Factor Concentrates: An Unmet Medical Need. J Cardiothorac Vase Anesth. 2015; 29(3): 768 - 76. doi: 10.1053/j.jvca.2015.02.023.

91. Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, B, EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, PiercyD, Gyte G. Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000 - 2004. Obstet Gynecol. 2007; 110(6): 1270 - 8. doi: 10.1097/01.AOG.0000288515.48066.99.

92. Huber A W, Raio L, Alberio L, Ghezzi F, Surbek D V. Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. J Perinat Med. 2011; 40(1): 43 - 9. doi: 10.1515/JPM.2011.109.

93. Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA, Australian and New Zealand Haemostasis Registry. Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. Anesth Analg. 2009; 109(6): 1908 - 15. doi: 10.1213/ANE.0b013e3181c039e6.

94. Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris J-C. Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. J Thromb Haemost. 2015; 13(4): 520 - 9. doi: 10.1111/jth.12844.

95. Franchini M, Manzato F, Salvagno GL, Lippi G. Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review. Blood Coagul Fibrinolysis. 2007; 18(7): 589 - 93. doi: 10.1097/MBC.0b013e32822d2a3c.

96. Brenner B, Wiis J. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency. Hematology. 2007; 12(1): 55 - 62.

doi: 10.1080/10245330601111573.

97. Shah NM, Chong SE, Yusoff SM, Mazlan MZ, Johan KB, Azman N, Lim JA, Mohamad SM, Noordin SS, Ghaffar ZA, Hassan MH, Zabidi MA, Rahim NAA. Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience. BMC Hematol. 2018; 18:34. doi: 10.1186/s12878-018-0126-z.

98. Liumbruno GM, Liumbruno C, Rafanelli D. Intraoperative cell salvage in obstetrics: is it a real therapeutic option? Transfusion. 2011; 51(10): 2244 - 56. doi: 10.1111/j.1537-2995.2011.03116.x.

99. Tevet A, Grisaru-Granovsky S, Samueloff A, loscovich A. Peripartum use of cell salvage: a university practice audit and literature review. Arch Gynecol Obstet. 2012; 285(2): 281 - 4. doi: 10.1007/s00404-011-2164-7.

100. Greenawa lt JA, Zernell D. Autologous Blood Transfusion for Postpartum Hemorrhage. MCN Am JMatem Child Nurs. 42(5): 269 - 75. doi: 10.1097/NMC.0000000000000359.

101. Lim G, Melnyk V, Facco FL, Waters JH, Smith KJ. Cost-effectiveness Analysis of Intraoperative Cell Salvage for Obstetric Hemorrhage. Anesthesiology. 2018; 128(2): 328 - 37. doi: 10.1097/ALN.0000000000001981.

102. Кровесберегающие технологии в акушерской практике. Клинические рекомендации (протокол лечения). Письмо Министерства здравоохранения РФ от 27 мая 2014 г. N 15-4/10/2-379839.

103. Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology. 2000; 92(6): 1531 - 6.

104. Working Party:, Association of Anaesthetists of Great Britain & Ireland, Obstetric Anaesthetists' Association, Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland The Obstetric Anaesthetists' Association Regional Anaesthesia UK. Anaesthesia. 2013; 68(9): 966 - 72. doi: 10.1111/anae.12359.

105. Horlocker TT, Vandermeuelen E, Kopp SL, Gogarten W, Lejfert LR, Benzon HT. Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Fourth Edition). Reg Anesth Pain Med. 2018; 43(3): 263 - 309.

doi: 10.1097/AAP.0000000000000763.

106. El Khouly NI. Comparison of intravenous ferrous sucrose and oral ferrous sulphate in treatment of postpartum iron deficiency anemia. J Matem Fetal Neonatal Med. 2017; 30(8): 967 - 71. doi: 10.1080/14767058.2016.1192602.